Capecitabine: have we got the dose right?
Author:
Publisher
Springer Science and Business Media LLC
Subject
Oncology,General Medicine
Link
http://www.nature.com/articles/ncponc1240.pdf
Reference24 articles.
1. Hoff PM et al. (2001) Comparison of oral capecitabine versus intravenous fluorouracil plus leucovorin as first line treatment in 605 patients with metastatic colorectal cancer: results of a randomised phase III study. J Clin Oncol 19: 2282–2292
2. Cassidy J et al. (2007) XELOX vs. FOLFOX4: efficacy results from XELOX-1/NO16966, a randomized phase III trial in first-line metastatic colorectal cancer (MCRC) [abstract #270]. In Proceedings of the Gastrointestinal Cancers Symposium: 2007 January 19–21; Orlando, FL
3. Scheithauer W et al. (2003) Oral capecitabine as an alternative to i.v. 5-fluorouracil-based adjuvant therapy for colon cancer: safety results of a randomized, phase III trial. Ann Oncol 14: 1735–1743
4. Maughan TS et al. (2002) Comparison of survival, palliation and quality of life with three chemotherapy regimens in metastatic colorectal cancer: a multicentre randomised trial. Lancet 359: 1555–1563
5. European Medicines Agency (online 31 March 2005) Scientific discussion [ http://www.emea.europa.eu/humandocs/PDFs/EPAR/Xeloda/282200en6.pdf ] (accessed 21 February 2008)
Cited by 64 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. A smart capecitabine imprinted nanocontainer with the dual-responsive performance to pH/NIR light;Materials Today Communications;2024-08
2. <i>Tarantula cubensisalcohol</i> extract enhances the tumoricidal effect of capecitabine via multiple pathways in azoxymethane-induced colorectal cancer in rats;Tropical Journal of Pharmaceutical Research;2024-03-12
3. Intake and biomarkers of folate and folic acid as determinants of chemotherapy-induced toxicities in patients with colorectal cancer: a cohort study;The American Journal of Clinical Nutrition;2024-02
4. Real-world data on adjuvant capecitabine after standard neoadjuvant chemotherapy for triple negative breast cancer;Revista Brasileira de Ginecologia e Obstetrícia;2024
5. Combination chemotherapy against colorectal cancer cells: Co-delivery of capecitabine and pioglitazone hydrochloride by polycaprolactone-polyethylene glycol carriers;Life Sciences;2023-11
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3